Who Paid My Doc
Interchangeability Study ABP 654
Research payments
$1,108,560
Through program year 2024, $1,108,560 in research payments was reported against Interchangeability Study ABP 654, across 50 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $3,690 | 1 |
| 2022 | Research | $1,083,568 | 48 |
| 2021 | Research | $21,301 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Lee San Antonio, TX Named on 2 payments
- Jerry Bagel East Windsor, NJ Named on 2 payments
- Abel Jarell Boston, MA Named on 2 payments
- Eduardo Weiss Hollywood, FL Named on 2 payments
- Andrew Blauvelt Portland, OR Named on 2 payments
- Tiffani Hamilton Alpharetta, GA Named on 2 payments
- Patricia Lee Webster, TX Named on 2 payments
- Melody Stone Saint Joseph, MO Named on 2 payments
- Jennifer Soung Santa Ana, CA Named on 2 payments
- Rosalyn George Wilmington, NC Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.